Exosomes as drug delivery systems in glioma immunotherapy
Abstract Recently, the significant benefits of cancer immunotherapy for most cancers have been demonstrated in clinical and preclinical studies. However, the efficacy of these immunotherapies for gliomas is limited, owing to restricted drug delivery and insufficient immune activation. As drug carrie...
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
BMC
2024-06-01
|
| Seri Bilgileri: | Journal of Nanobiotechnology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12951-024-02611-4 |